Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - ropivacaine hydrochloride - solution for injection - ropivacaine hydrochloride 10 mg/ml - anesthetics

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ropivacaine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ropivacaine hydrochloride -

Israel - English - Ministry of Health

neopharm (israel) 1996 ltd - ropivacaine as hydrochloride - solution for injection - ropivacaine as hydrochloride 2 mg/ml - ropivacaine - acute pain management :in adults and adolescents above 12 years of age for:- continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.- field blocks.- peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.

Israel - English - Ministry of Health

neopharm (israel) 1996 ltd - ropivacaine hydrochloride - solution for infusion - ropivacaine hydrochloride 2 mg/ml - ropivacaine - acute pain management :in adults and adolescents above 12 years of age for:- continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.- field blocks.- peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.

Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - ropivacaine hydrochloride - solution for injection - ropivacaine hydrochloride 5 mg/ml - anesthetics

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - ropivacaine hydrochloride - solution for injection - 2 milligram(s)/millilitre - amides; ropivacaine

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - ropivacaine hydrochloride - solution for injection - 7.5 milligram(s)/millilitre - amides; ropivacaine

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - ropivacaine hydrochloride 10 mg/ml equivalent to ropivacaine 8.85 mg/ml;   - solution for injection - 10 mg/ml - active: ropivacaine hydrochloride 10 mg/ml equivalent to ropivacaine 8.85 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - analgesia (adults and children over 12 years of age) · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain · field block (minor nerve block and infiltration) · continuous peripheral nerve block infusion or intermittent injections for postoperative pain management · continuous wound infusion for postoperative pain management (adults only) analgesia (children aged 0-12 years of age) · caudal epidural block in neonates (>37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years · continuous epidural infusion in infants (>30 days and over 2500 g weight) and children up to and including 12 years · peripheral nerve block in children aged 1 up to and including 12 years for peri- and postoperative pain management

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - ropivacaine hydrochloride 2 mg/ml equivalent to ropivacaine 1.77 mg/ml;   - solution for injection - 2 mg/ml - active: ropivacaine hydrochloride 2 mg/ml equivalent to ropivacaine 1.77 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - analgesia (adults and children over 12 years of age) · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain · field block (minor nerve block and infiltration) · continuous peripheral nerve block infusion or intermittent injections for postoperative pain management · continuous wound infusion for postoperative pain management (adults only) analgesia (children aged 0-12 years of age) · caudal epidural block in neonates (>37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years · continuous epidural infusion in infants (>30 days and over 2500 g weight) and children up to and including 12 years · peripheral nerve block in children aged 1 up to and including 12 years for peri- and postoperative pain management